Harman Finochem Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DAPAGLIFLOZIN, with a corresponding US DMF Number 32170.
Remarkably, this DMF maintains an Active status since its submission on November 09, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 06, 2017, and payment made on November 08, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II